NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia - Ribeiro, Renata Scopim; Machado Neto, João Agostinho; Eide, Christopher A.; Silva, Juan Luiz Coelho da; Fenerich, Bruna Alves; Fernandes, Jaqueline Cristina; Scheucher, Priscila Santos; Stevens, Samantha L. Savage; Campos, Paula de Melo; Saad, Sara T. Olalla; Palma, Leonardo de Carvalho; Pontes, Lorena Lobo de Figueiredo; et al. (Investigational New Drugs, 2021)